Literature DB >> 20227326

United virus: the oncolytic tag-team against cancer!

Fabrice Le Boeuf1, John C Bell.   

Abstract

There is an urgent need for innovative therapeutic strategies to treat aggressive metastatic cancers that are incurable with standard therapeutic approaches. Novel treatment strategies like oncolytic virotherapy have led, in some cases, to impressive effects on disease progression in human trials, suggesting that approval of an oncolytic virus therapeutic is on the horizon. While combinations of oncolytic viruses with small molecules are already being tested and have shown promise, we propose that even greater therapeutic synergies could be achieved through rational design of complementary virus therapeutics. In this review, we discuss rational chemical and biological combination strategies to enhance oncolytic virotherapy highlighting the promising combination of vaccinia and vesicular stomatitis oncolytic viruses. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20227326     DOI： 10.1016/j.cytogfr.2010.02.008

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN： 1359-6101            Impact factor:   7.638


  11 in total

1.  Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.

Authors:  Rohann J M Correa; Monica Komar; Jessica G K Tong; Milani Sivapragasam; Masmudur M Rahman; Grant McFadden; Gabriel E Dimattia; Trevor G Shepherd
Journal:  Gynecol Oncol       Date:  2012-02-01       Impact factor: 5.482

2.  Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.

Authors:  Michelle Cronin; Fabrice Le Boeuf; Carola Murphy; Dominic G Roy; Theresa Falls; John C Bell; Mark Tangney
Journal:  Mol Ther       Date:  2014-02-26       Impact factor: 11.454

Review 3.  Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Authors:  Steven S Yu; Tanya B Dorff; Leslie K Ballas; Sarmad Sadeghi; Eila C Skinner; David I Quinn
Journal:  Clin Adv Hematol Oncol       Date:  2017-06

4.  Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.

Authors:  Markus J V Vähä-Koskela; Fabrice Le Boeuf; Chantal Lemay; Naomi De Silva; Jean-Simon Diallo; Julie Cox; Michelle Becker; Youngmin Choi; Abhirami Ananth; Clara Sellers; Sophie Breton; Dominic Roy; Theresa Falls; Jan Brun; Akseli Hemminki; Ari Hinkkanen; John C Bell
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

5.  Oncolytic viruses in the treatment of bladder cancer.

Authors:  Kyle G Potts; Mary M Hitt; Ronald B Moore
Journal:  Adv Urol       Date:  2012-07-29

6.  Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.

Authors:  Steven J Conrad; Mohamed El-Aswad; Esaw Kurban; David Jeng; Brian C Tripp; Charles Nutting; Robert Eversole; Charles Mackenzie; Karim Essani
Journal:  J Exp Clin Cancer Res       Date:  2015-02-19

7.  Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models.

Authors:  Ciorsdan A Campion; Declan Soden; Patrick F Forde
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

8.  ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma.

Authors:  Ji Young Yoo; Jun-Ge Yu; Azeem Kaka; Quintin Pan; Pawan Kumar; Bhavna Kumar; Jianying Zhang; Andrew Mazar; Theodoros N Teknos; Balveen Kaur; Matthew O Old
Journal:  Mol Ther Oncolytics       Date:  2015-05-20       Impact factor: 7.200

Review 9.  The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.

Authors:  Adrian Pelin; Jiahu Wang; John Bell; Fabrice Le Boeuf
Journal:  Oncolytic Virother       Date:  2018-03-28

Review 10.  The current status of oncolytic viral therapy for head and neck cancer.

Authors:  Matthew O Old; Trisha Wise-Draper; Chadwick L Wright; Balveen Kaur; Theodoros Teknos
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.